about
An overview of the clinical use of antimuscarinics in the treatment of overactive bladderVardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.Preclinical compounds for the treatment of overactive bladder.Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?Fournier's gangrene, a urologic and surgical emergency: presentation of a multi-institutional experience with 45 cases.The medical treatment of overactive bladder, including current and future treatments.The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.Male overactive bladder: pharmacotherapy for the male.A review of cost-effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?Digital subtraction angiography and computer assisted image analysis for the evaluation of the antiangiogenetic effect of ionizing radiation on tumor angiogenesis.Primary adrenal tuberculosis: role of computed tomography and CT-guided biopsy in diagnosis.Case report: laparoscopic adrenalectomy in a patient with primary adrenal malignant melanoma.Appendicovesical fistula.Sociocultural and environmental influences on bladder health.Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.Primary echinococcal disease of the kidney: the case for a more conservative approach.Switching from long-term treatment with self-injections to oral sildenafil in diabetic patients with severe erectile dysfunction.Sildenafil test: changes in the diagnostic and therapeutic management of erectile dysfunction.Peyronie's disease: epidemiology and clinical presentation of 134 cases.Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.Gabapentin in the management of the recurrent, refractory, idiopathic priapism.Erectile dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the efficacy of sildenafil and continuous positive airway pressure.Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study.Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms.Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patient's satisfaction with treatment.The impact of long-term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive pulmonary disease) on concurrent erectile dysfunction.Treating stress urinary incontinence in female patients with neuropathic bladder: the value of the autologous fascia rectus sling.Efficacy and preoperative prognostic factors of autologous fascia rectus sling for treatment of female stress urinary incontinence.The pharmacotherapy of overactive bladder.The relationship between the perineal length measurements and the urodynamic stress incontinence.Paranephric abscess during pregnancy: a case for a low-dose interventional CT.Prostatectomy in the very aged.Unusual echinococcal cystSarcoidosis of the ureterIdiopathic granulomatous orchitisIntravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer
P50
Q35042575-F21301F5-2410-4EEB-AF7C-7B1BB67A79FEQ35824111-2AE8E019-10CD-443C-963A-5835A72793AFQ37481272-EC5DA953-313B-4D87-BE84-68AB8B1B0119Q37686408-9F282ABF-1110-4948-8723-3C63FE826019Q37826617-A1180281-1743-469F-83DE-9FA22CE88BF2Q37836943-AE7A67A5-7438-4E14-B13A-0406D8C43A50Q37865811-68A294D3-7C0D-41C1-8D2F-65C3FFD675B8Q38121403-37396D7E-E13D-4516-8EDC-C11188E0203FQ38345883-1C048C65-AFC6-48E6-955F-1F862EEAD839Q39771241-82BEC7A3-CC38-4FB9-86D0-37050BDADE03Q40481995-9F64D066-C420-4C68-B0C3-EC63A8596925Q40484989-33FA716E-5AE9-4B41-A4B0-37FD1B6D918CQ41047967-7C2BC713-622E-4D77-8A4C-C9479DBE4597Q43351741-D5BFCAE5-64EC-43D6-B9A0-AE272BD3E429Q43802464-262A889C-67F7-4702-87B6-84077C20E605Q43979086-118A3FF1-1F7B-42E2-B382-13B75A022FB4Q44035135-0A3C0DEB-0EE6-4D68-B725-A7F1CF96D250Q44046679-B327EEC0-9E5E-492E-8402-AEE1A4452BCFQ44232889-475773F4-4AC7-498B-A791-A3106015F953Q44456798-385C24E8-A837-4023-8ACD-4E3419CA8625Q44764447-1F01FCAD-80C5-4789-9954-EDA280502A1BQ44764470-816E1E8D-2B3A-491A-94FC-BAC813CBC302Q44824866-7958BAA0-64F5-4B9C-8C56-B4AAAC117D0EQ44944221-5044F5E7-EBF6-4FB4-9F4C-5654453093A9Q45153417-20B0B118-6511-440C-BF6C-3CE1B6839A8FQ46445226-15B391CA-C47C-4ED5-A7B1-7124033FAF48Q46954769-FB66076B-BC0D-41A4-9F42-0EDA98B38B9FQ47300736-5EA96DF8-1F03-4492-ADE3-8ABFAD279571Q48475570-87D3223A-7088-46AE-A501-2430B1F90353Q48494385-9566FDC9-527F-4C0F-8A74-3E6A63C692F7Q51323808-B13FBF7C-1B9D-4E7B-893D-0D65605F0132Q51392794-4E3E5F31-2F2E-4740-8916-AFF235BA66E0Q51759941-7963DA2F-7393-4052-9A63-52B97AA5A00CQ51827591-5F4434EA-FAD4-4073-B7FF-DA2DCCAC7C28Q53613740-A11604F0-D252-4EDA-8E5E-A5646C9AFF1EQ54070058-E33EB990-BB48-4056-8969-D4F7FD6B2936Q68045474-CD1C1D35-5DE2-403E-9FF5-4C9209DF5D1BQ68681460-6599B3A9-547C-45BC-803F-88464A5D75C8Q70143750-81715FAD-2F8E-427F-913B-5E30D03CB157Q70245435-7E192FF5-AEB3-4CFA-A418-F906DBF5ED94
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anastasios Athanasopoulos
@ast
Anastasios Athanasopoulos
@en
Anastasios Athanasopoulos
@es
Anastasios Athanasopoulos
@nl
Anastasios Athanasopoulos
@sl
type
label
Anastasios Athanasopoulos
@ast
Anastasios Athanasopoulos
@en
Anastasios Athanasopoulos
@es
Anastasios Athanasopoulos
@nl
Anastasios Athanasopoulos
@sl
altLabel
Athanassopoulos A
@en
prefLabel
Anastasios Athanasopoulos
@ast
Anastasios Athanasopoulos
@en
Anastasios Athanasopoulos
@es
Anastasios Athanasopoulos
@nl
Anastasios Athanasopoulos
@sl
P106
P21
P31
P496
0000-0003-3660-6699